Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aims to evaluate the effects of combined calcium and vitamin D3 supplementation on maternal, pregnancy, and neonatal outcomes.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Clinical data from 122 pregnant women were retrospectively analyzed and categorized into three groups based on their actual intake: control (n = 48), Calcium 600-Vitamin D (600 mg calcium + 1,000 IU vitamin D daily, n = 41), and Calcium 1,200-Vitamin D (1,200 mg calcium + 1,000 IU vitamin D daily, n = 33).

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The efficacy of calcium and vitamin D3 supplementation in improving pregnancy and neonatal outcomes

Study design awaiting verification · Frontiers in Pediatrics · 2025

Original publication title

The efficacy of calcium and vitamin D3 supplementation in improving pregnancy and neonatal outcomes

Fei Wang; Mengqing Shen; Ting Wu; Yang Zhang; Yun Wang; Congyun Zhou

© 2025 Wang, Shen, Wu, Zhang, Wang and Zhou.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study suggests that combined calcium and vitamin D₃ supplementation during pregnancy may help reduce the risk of pregnancy-related complications and improve neonatal outcomes, supporting its potential as an adjunct to prenatal care. Further large-scale and long-term studies are warranted to confirm these findings.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This study aims to evaluate the effects of combined calcium and vitamin D3 supplementation on maternal, pregnancy, and neonatal outcomes.

Source: Objective

Abstract: What methods does the paper describe?

Clinical data from 122 pregnant women were retrospectively analyzed and categorized into three groups based on their actual intake: control (n = 48), Calcium 600-Vitamin D (600 mg calcium + 1,000 IU vitamin D daily, n = 41), and Calcium 1,200-Vitamin D (1,200 mg calcium + 1,000 IU vitamin D daily, n = 33). Baseline characteristics and outcomes including gestational diabetes, preeclampsia, gestational hypertension, birth weight, and Apgar scores were collected and analyzed.

Source: Methods

Abstract: Results

Calcium and vitamin D₃ supplementation was associated with significantly lower rates of gestational diabetes (P = 0.035), preeclampsia (P = 0.032), and gestational hypertension (P = 0.047), as well as reduced leg cramp frequency (P < 0.001). Neonatal outcomes improved with higher birth weights (P < 0.001) and better 1-minute Apgar scores (P < 0.001). Multivariable logistic regression confirmed that high-dose supplementation (Calcium 1,200: Vitamin D) was independently associated with reduced risks of gestational diabetes (OR = 0.423, 95% CI: 0.123 to 0.869, P = 0.043) and gestational hypertension (OR = 0.342, 95% CI: 0.126 to 0.875, P = 0.012).

Both supplementation groups significantly reduced leg cramp frequency: Calcium 600: Vitamin D (OR = 0.507, 95% CI: 0.355 to 0.723, P < 0.001) and Calcium 1,200: Vitamin D (OR = 0.512, 95% CI: 0.256 to 0.985, P = 0.012). No significant differences were found in other outcomes including preterm birth, neonatal infection, or NICU admission (P > 0.05).

Source: Results

Abstract: Conclusion

This study suggests that combined calcium and vitamin D₃ supplementation during pregnancy may help reduce the risk of pregnancy-related complications and improve neonatal outcomes, supporting its potential as an adjunct to prenatal care. Further large-scale and long-term studies are warranted to confirm these findings.

Source: Conclusion
Authors’ abstract

Objective

This study aims to evaluate the effects of combined calcium and vitamin D3 supplementation on maternal, pregnancy, and neonatal outcomes.

Methods

Clinical data from 122 pregnant women were retrospectively analyzed and categorized into three groups based on their actual intake: control (n = 48), Calcium 600-Vitamin D (600 mg calcium + 1,000 IU vitamin D daily, n = 41), and Calcium 1,200-Vitamin D (1,200 mg calcium + 1,000 IU vitamin D daily, n = 33). Baseline characteristics and outcomes including gestational diabetes, preeclampsia, gestational hypertension, birth weight, and Apgar scores were collected and analyzed.

Results

Calcium and vitamin D₃ supplementation was associated with significantly lower rates of gestational diabetes (P = 0.035), preeclampsia (P = 0.032), and gestational hypertension (P = 0.047), as well as reduced leg cramp frequency (P < 0.001). Neonatal outcomes improved with higher birth weights (P < 0.001) and better 1-minute Apgar scores (P < 0.001). Multivariable logistic regression confirmed that high-dose supplementation (Calcium 1,200: Vitamin D) was independently associated with reduced risks of gestational diabetes (OR = 0.423, 95% CI: 0.123 to 0.869, P = 0.043) and gestational hypertension (OR = 0.342, 95% CI: 0.126 to 0.875, P = 0.012).

Both supplementation groups significantly reduced leg cramp frequency: Calcium 600: Vitamin D (OR = 0.507, 95% CI: 0.355 to 0.723, P < 0.001) and Calcium 1,200: Vitamin D (OR = 0.512, 95% CI: 0.256 to 0.985, P = 0.012). No significant differences were found in other outcomes including preterm birth, neonatal infection, or NICU admission (P > 0.05).

Conclusion

This study suggests that combined calcium and vitamin D₃ supplementation during pregnancy may help reduce the risk of pregnancy-related complications and improve neonatal outcomes, supporting its potential as an adjunct to prenatal care. Further large-scale and long-term studies are warranted to confirm these findings.

Publication and source details

Original title: The efficacy of calcium and vitamin D3 supplementation in improving pregnancy and neonatal outcomes

Fei Wang; Mengqing Shen; Ting Wu; Yang Zhang; Yun Wang; Congyun Zhou

Frontiers in Pediatrics · 2025

Edited by: Xin Li, Sichuan University, China

Reviewed by: Zhengtao Liu, Zhejiang Shuren University, China

Mehmet Tunç, Başkent University, Türkiye

Han Zo Choi, Kyung Hee University Hospital at Gangdong, Republic of Korea

* Correspondence: Congyun Zhou 18318287292@163.com
© 2025 Wang, Shen, Wu, Zhang, Wang and Zhou.2025Wang, Shen, Wu, Zhang, Wang and Zhouhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declare that no financial support was received for the research and/or publication of this article.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:46:05.415110+00:00

DOI: 10.3389/fped.2025.1605489 · PMC12207317